17beta-estradiol multiple interactions ISO RGD:1353558 6480464 [Estradiol co-treated with Progesterone] results in increased expression of ALDH1A3 mRNA, [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of ALDH1A3 mRNA CTD PMID:19619570 , PMID:20660070 17beta-estradiol decreases expression ISO RGD:1353558 6480464 Estradiol results in decreased expression of ALDH1A3 mRNA CTD PMID:28591870 , PMID:28711546 17beta-estradiol increases expression ISO RGD:1353558 6480464 Estradiol results in increased expression of ALDH1A3 mRNA CTD PMID:19619570 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression ISO RGD:1353558 6480464 Metribolone results in increased expression of ALDH1A3 mRNA CTD PMID:17526768 17beta-hydroxy-5alpha-androstan-3-one multiple interactions ISO RGD:1353558 6480464 AR protein promotes the reaction [Dihydrotestosterone results in increased expression of ALDH1A3 mRNA], bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of ALDH1A3 mRNA] CTD PMID:17526768 17beta-hydroxy-5alpha-androstan-3-one increases activity ISO RGD:1353558 6480464 Dihydrotestosterone results in increased activity of ALDH1A3 protein CTD PMID:17526768 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1353558 6480464 Dihydrotestosterone results in increased expression of ALDH1A3 mRNA CTD PMID:17526768 , PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1353558 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of ALDH1A3 mRNA more ... CTD PMID:14761676 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ALDH1A3 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1353558 6480464 Tetrachlorodibenzodioxin results in increased expression of ALDH1A3 mRNA CTD PMID:12377990 more ... 2,3,7,8-tetrachlorodibenzodioxine increases response to substance ISO RGD:733398 6480464 ALDH1A3 results in increased susceptibility to Tetrachlorodibenzodioxin CTD PMID:21807577 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:733398 6480464 Trinitrobenzenesulfonic Acid results in increased expression of ALDH1A3 mRNA CTD PMID:17982090 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of ALDH1A3 mRNA CTD PMID:21346803 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of ALDH1A3 mRNA CTD PMID:22584684 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:32119087 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:1353558 6480464 3 more ... CTD PMID:29947894 3,3',5-triiodo-L-thyronine multiple interactions ISO RGD:1353558 6480464 [Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in increased expression of ALDH1A3 mRNA CTD PMID:14761676 3,4-dichloroaniline increases expression EXP 6480464 3, 4-dichloroaniline results in increased expression of ALDH1A3 mRNA CTD PMID:24172598 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1353558 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ALDH1A3 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ALDH1A3 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol decreases expression ISO RGD:1353558 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of ALDH1A3 mRNA CTD PMID:28591870 5-aza-2'-deoxycytidine increases expression ISO RGD:1353558 6480464 Decitabine results in increased expression of ALDH1A3 mRNA CTD PMID:16367923 , PMID:21856257 5-aza-2'-deoxycytidine affects expression ISO RGD:1353558 6480464 Decitabine affects the expression of ALDH1A3 mRNA CTD PMID:17194187 , PMID:23300844 5-fluorouracil affects response to substance ISO RGD:1353558 6480464 ALDH1A3 protein affects the susceptibility to Fluorouracil CTD PMID:15352031 5-fluorouracil decreases expression ISO RGD:1353558 6480464 Fluorouracil results in decreased expression of ALDH1A3 protein CTD PMID:15352031 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases expression ISO RGD:1353558 6480464 Omeprazole results in increased expression of ALDH1A3 mRNA CTD PMID:12040753 acetamide increases expression EXP 6480464 acetamide results in increased expression of ALDH1A3 mRNA CTD PMID:31881176 adefovir pivoxil increases expression ISO RGD:1353558 6480464 adefovir dipivoxil results in increased expression of ALDH1A3 mRNA CTD PMID:25596134 aflatoxin B1 increases methylation ISO RGD:1353558 6480464 Aflatoxin B1 results in increased methylation of ALDH1A3 exon, Aflatoxin B1 results in increased methylation of ALDH1A3 gene CTD PMID:27153756 , PMID:30157460 aflatoxin B2 increases methylation ISO RGD:1353558 6480464 aflatoxin B2 results in increased methylation of ALDH1A3 exon CTD PMID:30157460 all-trans-retinal increases oxidation ISO RGD:1353558 6480464 ALDH1A3 protein results in increased oxidation of Retinaldehyde CTD PMID:17526768 all-trans-retinoic acid increases chemical synthesis ISO RGD:1353558 6480464 ALDH1A3 protein results in increased chemical synthesis of Tretinoin CTD PMID:17526768 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of ALDH1A3 mRNA, Tretinoin results in increased expression of ALDH1A3 protein CTD PMID:26672737 all-trans-retinoic acid multiple interactions EXP 6480464 Tretinoin promotes the reaction [nitrofen results in increased expression of ALDH1A3 mRNA] CTD PMID:26672737 all-trans-retinoic acid decreases expression ISO RGD:1353558 6480464 Tretinoin results in decreased expression of ALDH1A3 mRNA CTD PMID:21934132 , PMID:23724009 all-trans-retinoic acid increases chemical synthesis EXP 6480464 ALDH1A3 protein results in increased chemical synthesis of Tretinoin CTD PMID:21138835 all-trans-retinoic acid increases chemical synthesis ISO RGD:733398 6480464 ALDH1A3 protein results in increased chemical synthesis of Tretinoin, ALDH1A3 results in increased chemical synthesis of Tretinoin CTD PMID:16207763 more ... all-trans-retinoic acid multiple interactions ISO RGD:733398 6480464 [ALDH1A3 results in increased chemical synthesis of Tretinoin] which results in increased expression of AHR more ... CTD PMID:17207476 more ... all-trans-retinoic acid affects chemical synthesis ISO RGD:733398 6480464 ALDH1A3 protein affects the chemical synthesis of Tretinoin CTD PMID:14623956 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ALDH1A3 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:1353558 6480464 Antirheumatic Agents results in decreased expression of ALDH1A3 mRNA CTD PMID:24449571 arsenite(3-) decreases methylation ISO RGD:1353558 6480464 arsenite results in decreased methylation of ALDH1A3 promoter CTD PMID:23974009 arsenous acid increases expression ISO RGD:1353558 6480464 Arsenic Trioxide results in increased expression of ALDH1A3 protein CTD PMID:25419056 arsenous acid decreases expression ISO RGD:1353558 6480464 Arsenic Trioxide results in decreased expression of ALDH1A3 mRNA CTD PMID:26705709 arsenous acid multiple interactions ISO RGD:1353558 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ALDH1A3 protein] CTD PMID:26598702 atrazine increases expression ISO RGD:1353558 6480464 Atrazine results in increased expression of ALDH1A3 mRNA CTD PMID:22378314 benzo[a]pyrene increases expression ISO RGD:1353558 6480464 Benzo(a)pyrene results in increased expression of ALDH1A3 mRNA, Benzo(a)pyrene results in increased expression of ALDH1A3 protein CTD PMID:21714911 more ... benzo[a]pyrene decreases expression ISO RGD:733398 6480464 Benzo(a)pyrene results in decreased expression of ALDH1A3 mRNA CTD PMID:25908611 benzo[a]pyrene multiple interactions ISO RGD:1353558 6480464 PARG affects the reaction [Benzo(a)pyrene results in increased expression of ALDH1A3 protein] CTD PMID:25628927 benzo[a]pyrene increases expression ISO RGD:733398 6480464 Benzo(a)pyrene results in increased expression of ALDH1A3 mRNA CTD PMID:23735875 benzo[e]pyrene increases methylation ISO RGD:1353558 6480464 benzo(e)pyrene results in increased methylation of ALDH1A3 exon CTD PMID:30157460 bicalutamide multiple interactions ISO RGD:1353558 6480464 bicalutamide inhibits the reaction [Dihydrotestosterone results in increased expression of ALDH1A3 mRNA] CTD PMID:17526768 bis(2-chloroethyl) sulfide increases expression ISO RGD:1353558 6480464 Mustard Gas results in increased expression of ALDH1A3 mRNA CTD PMID:25102026 bisphenol A increases expression ISO RGD:1353558 6480464 bisphenol A results in increased expression of ALDH1A3 mRNA CTD PMID:22576693 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of ALDH1A3 gene CTD PMID:28505145 bisphenol A multiple interactions ISO RGD:1353558 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ALDH1A3 mRNA CTD PMID:28628672 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ALDH1A3 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:733398 6480464 bisphenol A results in increased expression of ALDH1A3 mRNA CTD PMID:26063408 , PMID:30951980 bisphenol A decreases expression ISO RGD:1353558 6480464 bisphenol A results in decreased expression of ALDH1A3 mRNA CTD PMID:28591870 , PMID:28711546 Bisphenol B decreases expression ISO RGD:1353558 6480464 bisphenol B results in decreased expression of ALDH1A3 mRNA CTD PMID:28591870 bisphenol F decreases expression ISO RGD:1353558 6480464 bisphenol F results in decreased expression of ALDH1A3 mRNA CTD PMID:28591870 bisphenol F increases expression ISO RGD:733398 6480464 bisphenol F results in increased expression of ALDH1A3 mRNA CTD PMID:30951980 bisphenol F multiple interactions ISO RGD:1353558 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ALDH1A3 mRNA CTD PMID:28628672 butan-1-ol multiple interactions ISO RGD:1353558 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ALDH1A3 mRNA CTD PMID:29432896 butanal increases expression ISO RGD:1353558 6480464 butyraldehyde results in increased expression of ALDH1A3 mRNA CTD PMID:26079696 butane-2,3-dione increases expression ISO RGD:1353558 6480464 Diacetyl results in increased expression of ALDH1A3 mRNA CTD PMID:30710127 cadmium dichloride decreases expression ISO RGD:1353558 6480464 Cadmium Chloride results in decreased expression of ALDH1A3 mRNA CTD PMID:25596134 calcitriol increases expression ISO RGD:1353558 6480464 Calcitriol results in increased expression of ALDH1A3 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1353558 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ALDH1A3 mRNA CTD PMID:21592394 carbon nanotube multiple interactions ISO RGD:1353558 6480464 [Nanotubes, Carbon co-treated with calfactant] results in increased expression of ALDH1A3 protein CTD PMID:23026733 carbon nanotube increases expression ISO RGD:733398 6480464 Nanotubes, Carbon analog results in increased expression of ALDH1A3 mRNA, Nanotubes, Carbon results in increased expression of ALDH1A3 mRNA CTD PMID:25554681 carmustine affects response to substance ISO RGD:1353558 6480464 ALDH1A3 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 chloroacetaldehyde increases expression ISO RGD:1353558 6480464 chloroacetaldehyde results in increased expression of ALDH1A3 mRNA CTD PMID:25596134 chloropicrin affects expression ISO RGD:1353558 6480464 chloropicrin affects the expression of ALDH1A3 mRNA CTD PMID:26352163 choline multiple interactions ISO RGD:733398 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ALDH1A3 mRNA CTD PMID:20938992 cidofovir anhydrous increases expression ISO RGD:1353558 6480464 Cidofovir results in increased expression of ALDH1A3 mRNA CTD PMID:25596134 cisplatin affects expression ISO RGD:1353558 6480464 Cisplatin affects the expression of ALDH1A3 mRNA CTD PMID:23300844 cisplatin multiple interactions ISO RGD:1353558 6480464 Cisplatin promotes the reaction [jinfukang results in increased expression of ALDH1A3 mRNA], jinfukang promotes the reaction [Cisplatin results in increased expression of ALDH1A3 mRNA] CTD PMID:27392435 cisplatin increases expression ISO RGD:1353558 6480464 Cisplatin results in increased expression of ALDH1A3 mRNA CTD PMID:25596134 clodronic acid increases expression ISO RGD:1353558 6480464 Clodronic Acid results in increased expression of ALDH1A3 mRNA CTD PMID:25596134 cobalt dichloride decreases expression ISO RGD:1353558 6480464 cobaltous chloride results in decreased expression of ALDH1A3 mRNA CTD PMID:19320972 crotonaldehyde increases expression ISO RGD:1353558 6480464 2-butenal results in increased expression of ALDH1A3 mRNA CTD PMID:20471460 cycloheximide multiple interactions ISO RGD:1353558 6480464 [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of ALDH1A3 mRNA CTD PMID:19684285 dexamethasone increases expression ISO RGD:1353558 6480464 Dexamethasone results in increased expression of ALDH1A3 mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO RGD:1353558 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ALDH1A3 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ALDH1A3 mRNA CTD PMID:28628672 diarsenic trioxide increases expression ISO RGD:1353558 6480464 Arsenic Trioxide results in increased expression of ALDH1A3 protein CTD PMID:25419056 diarsenic trioxide multiple interactions ISO RGD:1353558 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ALDH1A3 protein] CTD PMID:26598702 diarsenic trioxide decreases expression ISO RGD:1353558 6480464 Arsenic Trioxide results in decreased expression of ALDH1A3 mRNA CTD PMID:26705709 dibenzo[a,l]pyrene decreases expression ISO RGD:733398 6480464 dibenzo(a, l)pyrene results in decreased expression of ALDH1A3 mRNA CTD PMID:25908611 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of ALDH1A3 mRNA CTD PMID:21266533 dimethylarsinous acid increases expression ISO RGD:1353558 6480464 dimethylarsinous acid results in increased expression of ALDH1A3 mRNA CTD PMID:20886546 dioxygen affects expression ISO RGD:1353558 6480464 Oxygen deficiency affects the expression of ALDH1A3 mRNA CTD PMID:25596134 dioxygen multiple interactions ISO RGD:733398 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALDH1A3 mRNA CTD PMID:30529165 diuron increases expression EXP 6480464 Diuron metabolite results in increased expression of ALDH1A3 mRNA CTD PMID:24172598 dorsomorphin multiple interactions ISO RGD:1353558 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 entinostat increases expression ISO RGD:1353558 6480464 entinostat results in increased expression of ALDH1A3 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1353558 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALDH1A3 mRNA CTD PMID:27188386 ethyl methanesulfonate increases expression ISO RGD:1353558 6480464 Ethyl Methanesulfonate results in increased expression of ALDH1A3 mRNA CTD PMID:23649840 folic acid multiple interactions ISO RGD:733398 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ALDH1A3 mRNA CTD PMID:20938992 fonofos increases methylation ISO RGD:1353558 6480464 Fonofos results in increased methylation of ALDH1A3 promoter CTD PMID:22847954 formaldehyde increases expression ISO RGD:1353558 6480464 Formaldehyde results in increased expression of ALDH1A3 mRNA CTD PMID:23649840 furan increases expression EXP 6480464 furan results in increased expression of ALDH1A3 mRNA CTD PMID:27387713 gemcitabine increases expression ISO RGD:1353558 6480464 gemcitabine results in increased expression of ALDH1A3 mRNA CTD PMID:17039268 genistein decreases expression ISO RGD:1353558 6480464 Genistein results in decreased expression of ALDH1A3 mRNA CTD PMID:15378649 glyphosate decreases expression ISO RGD:1353558 6480464 glyphosate results in decreased expression of ALDH1A3 mRNA CTD PMID:28711546 graphite affects expression EXP 6480464 Graphite affects the expression of ALDH1A3 mRNA CTD PMID:29933104 hypochlorous acid increases expression ISO RGD:1353558 6480464 Hypochlorous Acid results in increased expression of ALDH1A3 mRNA CTD PMID:18156441 ifosfamide increases expression ISO RGD:1353558 6480464 Ifosfamide results in increased expression of ALDH1A3 mRNA CTD PMID:25596134 Indeno[1,2,3-cd]pyrene increases expression ISO RGD:1353558 6480464 indeno(1 more ... CTD PMID:32251684 indometacin multiple interactions ISO RGD:1353558 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ALDH1A3 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ALDH1A3 mRNA CTD PMID:28628672 isoflavones affects expression ISO RGD:1353558 6480464 Isoflavones affects the expression of ALDH1A3 mRNA CTD PMID:16365062 L-methionine multiple interactions ISO RGD:733398 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ALDH1A3 mRNA CTD PMID:20938992 lithium atom decreases expression EXP 6480464 Lithium results in decreased expression of ALDH1A3 protein CTD PMID:18296634 lithium chloride decreases expression ISO RGD:1353558 6480464 Lithium Chloride results in decreased expression of ALDH1A3 mRNA CTD PMID:15711924 lithium hydride decreases expression EXP 6480464 Lithium results in decreased expression of ALDH1A3 protein CTD PMID:18296634 menadione affects expression ISO RGD:733398 6480464 Vitamin K 3 affects the expression of ALDH1A3 mRNA CTD PMID:20829426 mercury dibromide increases expression ISO RGD:1353558 6480464 mercuric bromide results in increased expression of ALDH1A3 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1353558 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALDH1A3 mRNA CTD PMID:27188386 methapyrilene increases methylation ISO RGD:1353558 6480464 Methapyrilene results in increased methylation of ALDH1A3 exon CTD PMID:30157460 methyl methanesulfonate increases expression ISO RGD:1353558 6480464 Methyl Methanesulfonate results in increased expression of ALDH1A3 mRNA CTD PMID:23649840 monosodium L-glutamate increases expression ISO RGD:733398 6480464 Sodium Glutamate results in increased expression of ALDH1A3 mRNA CTD PMID:22078008 N-acetyl-1,4-benzoquinone imine affects response to substance ISO RGD:1353558 6480464 ALDH1A3 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine CTD PMID:21177773 N-nitrosodiethylamine multiple interactions EXP 6480464 [Mastic Resin co-treated with Diethylnitrosamine] results in decreased expression of ALDH1A3 mRNA CTD PMID:18977376 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of ALDH1A3 protein CTD PMID:24972641 nitrofen multiple interactions EXP 6480464 Tretinoin promotes the reaction [nitrofen results in increased expression of ALDH1A3 mRNA] CTD PMID:26672737 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of ALDH1A3 mRNA CTD PMID:17270546 , PMID:26672737 omeprazole increases expression ISO RGD:1353558 6480464 Omeprazole results in increased expression of ALDH1A3 mRNA CTD PMID:12040753 ozone multiple interactions ISO RGD:733398 6480464 [NOTCH3 gene mutant form affects the susceptibility to Ozone] which affects the expression of ALDH1A3 mRNA CTD PMID:25658374 panobinostat multiple interactions ISO RGD:1353558 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALDH1A3 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1353558 6480464 panobinostat results in increased expression of ALDH1A3 mRNA CTD PMID:26272509 parathion increases methylation ISO RGD:1353558 6480464 Parathion results in increased methylation of ALDH1A3 promoter CTD PMID:22847954 pentanal increases expression ISO RGD:1353558 6480464 pentanal results in increased expression of ALDH1A3 mRNA CTD PMID:26079696 pentane-2,3-dione increases expression ISO RGD:1353558 6480464 2, 3-pentanedione results in increased expression of ALDH1A3 mRNA CTD PMID:30710127 phenylmercury acetate increases expression ISO RGD:1353558 6480464 Phenylmercuric Acetate results in increased expression of ALDH1A3 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1353558 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALDH1A3 mRNA CTD PMID:27188386 picene increases expression ISO RGD:1353558 6480464 picene results in increased expression of ALDH1A3 mRNA CTD PMID:32251684 piroxicam decreases expression ISO RGD:1353558 6480464 Piroxicam results in decreased expression of ALDH1A3 mRNA CTD PMID:21858171 potassium chromate decreases expression ISO RGD:1353558 6480464 potassium chromate(VI) results in decreased expression of ALDH1A3 mRNA CTD PMID:22714537 pravastatin affects expression EXP 6480464 Pravastatin affects the expression of ALDH1A3 mRNA CTD PMID:27225895 pravastatin affects expression ISO RGD:733398 6480464 Pravastatin affects the expression of ALDH1A3 mRNA CTD PMID:27225895 progesterone multiple interactions ISO RGD:1353558 6480464 [Estradiol co-treated with Progesterone] results in increased expression of ALDH1A3 mRNA CTD PMID:20660070 progesterone decreases expression ISO RGD:733398 6480464 Progesterone results in decreased expression of ALDH1A3 mRNA CTD PMID:22238285 propanal increases expression ISO RGD:1353558 6480464 propionaldehyde results in increased expression of ALDH1A3 mRNA CTD PMID:26079696 resveratrol decreases expression ISO RGD:1353558 6480464 resveratrol results in decreased expression of ALDH1A3 mRNA CTD PMID:18586690 SB 431542 multiple interactions ISO RGD:1353558 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1353558 6480464 Silicon Dioxide analog results in increased expression of ALDH1A3 mRNA CTD PMID:25895662 sodium arsenate decreases expression ISO RGD:1353558 6480464 sodium arsenate results in decreased expression of ALDH1A3 mRNA CTD PMID:12727804 sodium arsenite decreases expression ISO RGD:1353558 6480464 sodium arsenite results in decreased expression of ALDH1A3 mRNA CTD PMID:12727804 , PMID:29301061 sulforaphane decreases expression ISO RGD:1353558 6480464 sulforafan results in decreased expression of ALDH1A3 mRNA CTD PMID:31838189 Tanshinone I decreases expression ISO RGD:1353558 6480464 tanshinone results in decreased expression of ALDH1A3 mRNA CTD PMID:15849732 tebuconazole decreases expression ISO RGD:1353558 6480464 tebuconazole results in decreased expression of ALDH1A3 mRNA CTD PMID:30458266 temozolomide affects response to substance ISO RGD:1353558 6480464 ALDH1A3 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 terbufos increases methylation ISO RGD:1353558 6480464 terbufos results in increased methylation of ALDH1A3 promoter CTD PMID:22847954 tert-butyl hydroperoxide increases expression ISO RGD:1353558 6480464 tert-Butylhydroperoxide results in increased expression of ALDH1A3 mRNA CTD PMID:15336504 testosterone multiple interactions ISO RGD:1353558 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ALDH1A3 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:1353558 6480464 Testosterone results in increased expression of ALDH1A3 mRNA CTD PMID:21592394 testosterone enanthate affects expression ISO RGD:1353558 6480464 testosterone enanthate affects the expression of ALDH1A3 mRNA CTD PMID:17440010 thapsigargin decreases expression ISO RGD:1353558 6480464 Thapsigargin results in decreased expression of ALDH1A3 mRNA CTD PMID:22378314 trichostatin A increases expression ISO RGD:1353558 6480464 trichostatin A results in increased expression of ALDH1A3 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1353558 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALDH1A3 mRNA CTD PMID:27188386 trimellitic anhydride decreases expression ISO RGD:733398 6480464 trimellitic anhydride results in decreased expression of ALDH1A3 mRNA CTD PMID:19042947 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of ALDH1A3 mRNA CTD PMID:30589522 valproic acid affects expression ISO RGD:1353558 6480464 Valproic Acid affects the expression of ALDH1A3 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1353558 6480464 Valproic Acid results in increased expression of ALDH1A3 mRNA CTD PMID:24383497 , PMID:24935251 vorinostat multiple interactions ISO RGD:1353558 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALDH1A3 mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:1353558 6480464 vorinostat results in increased expression of ALDH1A3 mRNA CTD PMID:26272509 zaragozic acid A decreases expression ISO RGD:733398 6480464 squalestatin 1 results in decreased expression of ALDH1A3 mRNA CTD PMID:27225895 zaragozic acid A decreases expression EXP 6480464 squalestatin 1 results in decreased expression of ALDH1A3 mRNA CTD PMID:27225895 zoledronic acid increases expression ISO RGD:1353558 6480464 zoledronic acid results in increased expression of ALDH1A3 mRNA CTD PMID:24714768 , PMID:25596134
Biological Process embryonic camera-type eye development ISO RGD:733398 1624291 MGI:MGI:107928 (MGI:MGI:3042765 more ... RGD MGI:MGI:3042765 more ... embryonic eye morphogenesis ISO RGD:733398 1624291 MGI:MGI:1353450 more ... RGD MGI:MGI:3608158 more ... face development ISO RGD:733398 1624291 MGI:MGI:107928 (MGI:MGI:3700411 , PMID:17184764) RGD MGI:MGI:3700411 , PMID:17184764 face development IEA UniProtKB:Q9JHW9 , ensembl:ENSMUSP000000152781600115 GO_REF:0000107 Ensembl GO_REF:0000107 Harderian gland development IEA UniProtKB:Q9JHW9 , ensembl:ENSMUSP000000152781600115 GO_REF:0000107 Ensembl GO_REF:0000107 Harderian gland development ISO RGD:733398 1624291 (MGI:MGI:3042765, PMID:14623956) RGD MGI:MGI:3042765 , PMID:14623956 inner ear morphogenesis ISO RGD:733398 1624291 MGI:MGI:3043947 (MGI:MGI:5488831 , PMID:23536097) RGD MGI:MGI:5488831 , PMID:23536097 inner ear morphogenesis IEA UniProtKB:Q9JHW9 , ensembl:ENSMUSP000000152781600115 GO_REF:0000107 Ensembl GO_REF:0000107 kidney development IEP 2306322 RGD locomotory behavior ISO RGD:733398 1624291 MGI:MGI:3043947 (MGI:MGI:5488831 , PMID:23536097) RGD MGI:MGI:5488831 , PMID:23536097 locomotory behavior IEA UniProtKB:Q9JHW9 , ensembl:ENSMUSP000000152781600115 GO_REF:0000107 Ensembl GO_REF:0000107 neuromuscular process controlling balance ISO RGD:733398 1624291 MGI:MGI:3043947 (MGI:MGI:5488831 , PMID:23536097) RGD MGI:MGI:5488831 , PMID:23536097 neuromuscular process controlling balance IEA UniProtKB:Q9JHW9 , ensembl:ENSMUSP000000152781600115 GO_REF:0000107 Ensembl GO_REF:0000107 nose development ISO RGD:733398 1624291 (MGI:MGI:3042765, PMID:14623956) RGD MGI:MGI:3042765 , PMID:14623956 nucleus accumbens development ISO RGD:733398 1624291 MGI:MGI:3512079 (MGI:MGI:3701419 , PMID:17207476) RGD MGI:MGI:3701419 , PMID:17207476 nucleus accumbens development IEA UniProtKB:Q9JHW9 , ensembl:ENSMUSP000000152781600115 GO_REF:0000107 Ensembl GO_REF:0000107 olfactory pit development ISO RGD:733398 1624291 MGI:MGI:3512079 (MGI:MGI:3701419 , PMID:17207476) RGD MGI:MGI:3701419 , PMID:17207476 olfactory pit development IEA UniProtKB:Q9JHW9 , ensembl:ENSMUSP000000152781600115 GO_REF:0000107 Ensembl GO_REF:0000107 optic cup morphogenesis involved in camera-type eye development ISO RGD:733398 1624291 MGI:MGI:1353450 (MGI:MGI:3624188 , PMID:16611695) RGD MGI:MGI:3624188 , PMID:16611695 optic cup morphogenesis involved in camera-type eye development IEA UniProtKB:Q9JHW9 , ensembl:ENSMUSP000000152781600115 GO_REF:0000107 Ensembl GO_REF:0000107 oxidation-reduction process IEA InterPro:IPR015590 more ... 1600115 GO_REF:0000002 InterPro GO_REF:0000002 oxidation-reduction process IEA UniProtKB-KW:KW-0560 1600115 GO_REF:0000043 UniProt GO_REF:0000043 pituitary gland development IEP 2306413 RGD positive regulation of apoptotic process ISO RGD:733398 1624291 MGI:MGI:1353450 more ... RGD MGI:MGI:3608158 more ... positive regulation of apoptotic process IEA UniProtKB:Q9JHW9 , ensembl:ENSMUSP000000152781600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein homotetramerization IEA UniProtKB:P47895 , ensembl:ENSP000003322561600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein homotetramerization ISS UniProtKB:P47895 1600115 GO_REF:0000024 UniProt GO_REF:0000024 protein homotetramerization ISO RGD:1353558 1624291 (PMID:27759097) RGD PMID:27759097 response to drug IEP 634541 phenobarbital RGD retinal metabolic process ISO RGD:1353558 1624291 (PMID:11585737) RGD PMID:11585737 retinal metabolic process IEA UniProtKB:P47895 , ensembl:ENSP000003322561600115 GO_REF:0000107 Ensembl GO_REF:0000107 retinoic acid biosynthetic process IEP 6771322 RGD retinoic acid biosynthetic process ISS UniProtKB:P47895 1600115 GO_REF:0000024 UniProt GO_REF:0000024 retinoic acid biosynthetic process IEA UniProtKB:Q9JHW9 , ensembl:ENSMUSP000000152781600115 GO_REF:0000107 Ensembl GO_REF:0000107 retinoic acid biosynthetic process ISO RGD:733398 1624291 (MGI:MGI:1927016 more ... RGD MGI:MGI:1927016 more ... retinoic acid biosynthetic process IMP 6771354 RGD retinoic acid biosynthetic process IEA UniProtKB:P47895 , ensembl:ENSP000003322561600115 GO_REF:0000107 Ensembl GO_REF:0000107 retinoic acid biosynthetic process ISO RGD:1353558 1624291 (PMID:27759097) RGD PMID:27759097 retinoic acid metabolic process ISO RGD:1353558 1624291 (PMID:11585737) RGD PMID:11585737 retinoic acid metabolic process ISO RGD:733398 1624291 MGI:MGI:1353450 more ... RGD MGI:MGI:3608158 more ... retinol metabolic process IEA UniPathway:UPA00912 1600115 GO_REF:0000041 UniProt GO_REF:0000041 righting reflex ISO RGD:733398 1624291 MGI:MGI:3043947 (MGI:MGI:5488831 , PMID:23536097) RGD MGI:MGI:5488831 , PMID:23536097 righting reflex IEA UniProtKB:Q9JHW9 , ensembl:ENSMUSP000000152781600115 GO_REF:0000107 Ensembl GO_REF:0000107 Cellular Component cytoplasm ISO RGD:733398 1624291 (MGI:MGI:3834559, PMID:16615129) RGD MGI:MGI:3834559 , PMID:16615129 cytoplasm IEA UniProtKB:Q9JHW9 , ensembl:ENSMUSP000000152781600115 GO_REF:0000107 Ensembl GO_REF:0000107 cytoplasm IEA UniProtKB:P47895 , ensembl:ENSP000003322561600115 GO_REF:0000107 Ensembl GO_REF:0000107 cytoplasm ISO RGD:1353558 1624291 (PMID:11585737) RGD PMID:11585737 cytosol NAS 634541 RGD Molecular Function aldehyde dehydrogenase (NAD+) activity ISO RGD:733398 1624291 (MGI:MGI:3055622 more ... RGD MGI:MGI:3055622 more ... aldehyde dehydrogenase (NAD+) activity IBA FB:FBgn0012036 more ... 13792537 PMID:21873635 GO_Central aldehyde dehydrogenase (NAD+) activity IEA UniProtKB:Q9JHW9 , ensembl:ENSMUSP000000152781600115 GO_REF:0000107 Ensembl GO_REF:0000107 aldehyde dehydrogenase [NAD(P)+] activity IDA 634541 RGD aldehyde dehydrogenase [NAD(P)+] activity ISO RGD:1353558 1624291 (PMID:11585737) RGD PMID:11585737 aldehyde dehydrogenase [NAD(P)+] activity ISO RGD:733398 1624291 (MGI:MGI:1927016, PMID:11044606) RGD MGI:MGI:1927016 , PMID:11044606 NAD+ binding ISO RGD:733398 1624291 (MGI:MGI:3692370, PMID:16241904) RGD MGI:MGI:3692370 , PMID:16241904 NAD+ binding IEA UniProtKB:Q9JHW9 , ensembl:ENSMUSP000000152781600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein homodimerization activity ISO RGD:1353558 1624291 (PMID:11585737) RGD PMID:11585737 protein homodimerization activity IEA UniProtKB:P47895 , ensembl:ENSP000003322561600115 GO_REF:0000107 Ensembl GO_REF:0000107 retinal dehydrogenase activity ISO RGD:1353558 1624291 (PMID:27759097) RGD PMID:27759097 retinal dehydrogenase activity ISS UniProtKB:P47895 1600115 GO_REF:0000024 UniProt GO_REF:0000024 retinal dehydrogenase activity IEA UniProtKB:P47895 , ensembl:ENSP000003322561600115 GO_REF:0000107 Ensembl GO_REF:0000107 thyroid hormone binding ISO RGD:733398 1624291 CHEBI:18258 (MGI:MGI:3692370, PMID:16241904) RGD MGI:MGI:3692370 , PMID:16241904 thyroid hormone binding IEA UniProtKB:Q9JHW9 , ensembl:ENSMUSP000000152781600115 GO_REF:0000107 Ensembl GO_REF:0000107
Gene-Chemical Interaction Annotations
